Cargando…
Overexpression of miR-221 in sudden death with cardiac hypertrophy patients
BACKGROUND: Cardiac hypertrophy is a well-known risk factor for heart failure and sudden cardiac death (SCD). On the other hand, physiological cardiac hypertrophy is often observed in young healthy men, and it is difficult to predict SCD in cardiac hypertrophy subjects who do not show symptoms of he...
Autores principales: | Kakimoto, Yu, Tanaka, Masayuki, Hayashi, Hideki, Yokoyama, Keiko, Osawa, Motoki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041564/ https://www.ncbi.nlm.nih.gov/pubmed/30009269 http://dx.doi.org/10.1016/j.heliyon.2018.e00639 |
Ejemplares similares
-
Proteomic profiling of sudden cardiac death with acquired cardiac hypertrophy
por: Kakimoto, Yu, et al.
Publicado: (2023) -
Myocardial cathepsin D is downregulated in sudden cardiac death
por: Kakimoto, Yu, et al.
Publicado: (2020) -
Myocardial lipofuscin accumulation in ageing and sudden cardiac death
por: Kakimoto, Yu, et al.
Publicado: (2019) -
Evaluation of cardiac hypertrophy in the setting of sudden cardiac death
por: Cunningham, Kristopher S., et al.
Publicado: (2019) -
Non-polyalanine repeat mutation in PHOX2B is detected in autopsy cases of sudden unexpected infant death
por: Ueda, Atsushi, et al.
Publicado: (2022)